Advance Care Planning for Cancer
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial explores the best way to assist patients with advanced cancer in planning their future healthcare. It compares two methods: in-person or phone discussions with a guide (facilitated advance care planning) and a web-based tool for planning (web-based advance care planning). The trial will also examine how these methods impact healthcare usage and costs at the end of life. Patients with solid tumors who may not live beyond a year and are open to either form of planning might be suitable candidates. The study also involves caregivers who play a significant role in the patient's care. As an unphased trial, it provides patients the opportunity to contribute to valuable research that could enhance future healthcare planning for others.
Will I have to stop taking my current medications?
The trial information does not specify whether you need to stop taking your current medications.
What prior data suggests that these advance care planning strategies are safe for patients with advanced cancer?
Research has shown that advance care planning (ACP), whether conducted in person or online, is safe. This planning ensures that medical care aligns with patients' end-of-life wishes. Studies have found that ACP improves engagement and leads to the completion of important documents like advance directives, which are legal papers stating a person's healthcare preferences.
Online tools for advance care planning, such as the PREPARE website, have also undergone study. These tools are user-friendly and often include videos to guide users through the planning steps. Reviews have found these tools effective for patients with cancer, helping them receive more care at home rather than in hospitals.
Both in-person and online methods aim to enhance communication and ensure that medical care respects patients' goals and preferences. No serious safety issues have been reported for either method, indicating that both types of ACP are safe and well-tolerated options for patients considering joining a clinical trial.12345Why are researchers excited about this trial?
Researchers are excited about this trial because it explores unique methods for advance care planning (ACP) in cancer treatment. Unlike traditional approaches, which often involve face-to-face meetings with healthcare providers, this trial examines the effectiveness of facilitated ACP through both in-person/telephonic discussions and a web-based platform. The facilitated ACP uses the Respecting Choices model, which provides structured support for patients, while the web-based option leverages the PREPARE website to offer flexibility and accessibility. These innovative approaches aim to empower patients by making advance care planning more accessible and tailored to individual preferences, potentially improving patient engagement and decision-making about their care.
What evidence suggests that this trial's advance care planning strategies could be effective for patients with advanced cancer?
This trial will compare two methods of advance care planning (ACP) for cancer patients. Research has shown that assistance with ACP, either in person or over the phone, results in more people completing their advance directives compared to some other methods. This approach encourages patients to engage more actively in planning their future healthcare. Participants in one arm of this trial will receive facilitated ACP discussions using the Respecting Choices model.
The other arm will involve web-based ACP via the PREPARE website. Online ACP programs like PREPARE have also succeeded in encouraging patients to plan their care in various settings. Studies have found that online ACP can lead to more care being provided at home rather than in the hospital. Both methods aim to help patients make healthcare decisions that align with their personal values and preferences.12567Who Is on the Research Team?
Yael Schenker, MD, MAS
Principal Investigator
University of Pittsburgh
Are You a Good Fit for This Trial?
This trial is for adults with advanced cancer who are expected to continue care at a participating clinic, can participate in either web-based or facilitated advance care planning (ACP), and have someone involved in their care. Excluded are those without phone access, unable to consent, with blood cancers, or unable to complete the baseline interview.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants receive either in-person facilitated ACP discussions or web-based ACP using interactive videos
Follow-up
Participants are monitored for outcomes such as ACP engagement and healthcare utilization until 12 weeks after the patient's death or completion of the 48-month data collection period
What Are the Treatments Tested in This Trial?
Interventions
- Facilitated advance care planning (in-person or telephonic)
- Web-based advance care planning
Find a Clinic Near You
Who Is Running the Clinical Trial?
University of Pittsburgh
Lead Sponsor
National Cancer Institute (NCI)
Collaborator